Risperidone was developed in the 1990s because clozapine was involved in the deaths of some people from a blood condition called agranulocytosis. Risperidone like clozapine binds to dopamine and serotonin receptors. But risperidone binds more strongly to dopamine receptors and is therefore more effective in smaller doses than most antipsychotics and has fewer side effects.